Drug profile · INN
tividenofusp alfa-eknm
AVLAYAH
tividenofusp alfa-eknm (AVLAYAH) is an FDA-listed pharmaceutical active ingredient. Associated with Denali Therapeutics. Route of administration: powder,for solution. Current US regulatory status: approved.
Drug details — tividenofusp alfa-eknm
- US status
- approved
- Class
- —
- Route
- POWDER,FOR SOLUTION
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
tividenofusp alfa-eknm (AVLAYAH) is an FDA-listed pharmaceutical active ingredient. Associated with Denali Therapeutics. Route of administration: powder,for solution. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related patents
-
US 12378540
Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof
granted -
US 12358928
Compounds, compositions and methods
granted -
US 12180211
Compounds, compositions and methods
granted -
US 11958840
Compounds, compositions and methods
granted -
US 11884944
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof
granted -
US 11851440
Modulators of eukaryotic initiation factor 2B, compositions and methods
granted -
US 11851433
Compounds, compositions and methods
granted -
US 11834439
Compounds, compositions, and methods
granted -
US 11643446
Progranulin variants
granted -
US 11591316
Compounds, compositions, and methods
granted -
US 11427571
Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
granted -
US 11306077
Compounds, compositions and methods
granted -
US 11236100
Modulators of eukaryotic initiation factor 2B, compositions and methods
granted -
US 11214565
Compound, compositions, and methods
granted -
US 11174262
Compounds, compositions and methods
granted -
US 11111235
Compounds, compositions, and methods
granted -
US 11072618
Compounds, compositions and methods
granted -
US 10851088
Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
granted -
US 10604535
Compounds, compositions and methods
granted -
US 10590114
Compounds, compositions, and methods
granted
Frequently asked questions
What is tividenofusp alfa-eknm?
tividenofusp alfa-eknm (AVLAYAH) is an FDA-listed pharmaceutical active ingredient. Associated with Denali Therapeutics. Route of administration: powder,for solution. Current US regulatory status: approved.
What is the brand name for tividenofusp alfa-eknm?
AVLAYAH is a marketed brand name for tividenofusp alfa-eknm. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tividenofusp alfa-eknm?
tividenofusp alfa-eknm has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.